Healthpeak Properties (NYSE:PEAK) Given New $32.50 Price Target at Morgan Stanley

Healthpeak Properties (NYSE:PEAKGet Rating) had its price objective decreased by stock analysts at Morgan Stanley from $34.50 to $32.50 in a report released on Wednesday, Stock Target Advisor reports. The firm currently has an “equal weight” rating on the stock. Morgan Stanley’s price target suggests a potential upside of 11.76% from the stock’s previous close.

A number of other equities analysts have also recently issued reports on PEAK. Bank of America cut shares of Healthpeak Properties from a “buy” rating to a “neutral” rating and set a $32.00 target price on the stock. in a report on Thursday, May 19th. Credit Suisse Group raised their price target on shares of Healthpeak Properties from $37.00 to $38.00 and gave the company a “neutral” rating in a research note on Monday, April 4th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $36.17.

Shares of PEAK stock traded down $0.61 during trading hours on Wednesday, hitting $29.08. 45,975 shares of the company were exchanged, compared to its average volume of 4,497,937. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.87 and a current ratio of 0.87. Healthpeak Properties has a one year low of $28.65 and a one year high of $37.69. The business’s 50-day simple moving average is $32.71 and its two-hundred day simple moving average is $33.52. The stock has a market capitalization of $15.69 billion, a price-to-earnings ratio of 36.70, a P/E/G ratio of 3.26 and a beta of 0.73.

Healthpeak Properties (NYSE:PEAKGet Rating) last issued its quarterly earnings results on Tuesday, May 3rd. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.29). Healthpeak Properties had a return on equity of 4.22% and a net margin of 22.11%. The company had revenue of $498.40 million for the quarter, compared to the consensus estimate of $490.02 million. During the same period in the previous year, the business posted $0.40 EPS. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. As a group, analysts anticipate that Healthpeak Properties will post 1.74 EPS for the current fiscal year.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. GHP Investment Advisors Inc. acquired a new position in Healthpeak Properties in the first quarter worth approximately $26,000. Cyrus J. Lawrence LLC acquired a new position in Healthpeak Properties in the first quarter worth approximately $29,000. Nauset Wealth Management. LLC acquired a new position in Healthpeak Properties in the first quarter worth approximately $29,000. Carl Stuart Investment Advisor Inc. acquired a new position in Healthpeak Properties in the first quarter worth approximately $32,000. Finally, Certified Advisory Corp acquired a new position in Healthpeak Properties in the first quarter worth approximately $33,000. Institutional investors and hedge funds own 95.98% of the company’s stock.

Healthpeak Properties Company Profile (Get Rating)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles.

Further Reading

Stock Target Advisor logo

Analyst Recommendations for Healthpeak Properties (NYSE:PEAK)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.